Bezetabart debotansine | Interleukin Related interleukin-related.com

Product Name :
Bezetabart debotansine

Search keywords :
Debotansine

drugId :
null

Target Vo:
HLA-DR antigens-associated invariant chain

Target Vo Short Name :
HLA-DR

Moa_Name:
Anti-CD74

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Sutro Biopharma Inc

Active Company_Name :
Bionova Pharmaceuticals (Shanghai) Ltd

Active Indication_Name:
Hematologic Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
TRAF6 Rabbit mAb In stock
BRD4 Antibody supplier
Glucosidase 2 subunit beta Antibody: Glucosidase 2 subunit beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 59 kDa., targeting to Glucosidase 2 subunit beta. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts